Phase II Study of Azacitidine in Myelofibrosis.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2012
At a glance
- Drugs Azacitidine (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 29 Mar 2011 Actual end date changed from Dec 2008 to Apr 2008 as reported by ClinicalTrials.gov.
- 29 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2011 New trial record